Berenberg analyst Luisa Hector raised the firm’s price target on Novo Nordisk to DKK 850 from DKK 650 and keeps a Hold rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVO:
- Viking Therapeutics soars after obesity drug trial hits targets
- Deutsche says Viking data shows GLP-1 market may not be duopoly
- Viking Therapeutics obesity data ‘best-case scenario,’ says Truist
- Eli Lilly, Novo Nordisk shares fall after Viking Therapeutics obesity results
- Viking Therapeutics jumps 103% to $79.11 after obesity study hits endpoints